Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
129.06
+9.13 (7.61%)
At close: Apr 24, 2026, 4:00 PM EDT
128.95
-0.11 (-0.09%)
After-hours: Apr 24, 2026, 7:46 PM EDT

Inhibrx Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,8851,1522231,8001,0731,703
Market Cap Growth
954.49%416.59%-87.61%67.69%-36.96%36.95%
Enterprise Value
1,8681,13276.791,7301,0051,647
Last Close Price
129.0679.0015.4038.0024.6443.67
PE Ratio
--8.740.14-1.86-6.81-20.31
PS Ratio
1450.14885.871114.641000.02489.70235.48
PB Ratio
235.38144.081.6741.3818.4932.51
P/TBV Ratio
250.06153.071.7310.2917.0231.69
P/FCF Ratio
--8.87-1.13-9.10-9.25-20.97
P/OCF Ratio
--8.87-1.15-9.31-9.31-21.20
EV/Sales Ratio
1436.90870.84383.93961.22458.40227.76
EV/EBITDA Ratio
--8.54-0.23-7.94-7.86-21.85
EV/EBIT Ratio
--8.38-0.23-7.89-7.78-21.51
EV/FCF Ratio
--8.72-0.39-8.74-8.66-20.29
Debt / Equity Ratio
13.1013.100.054.783.541.44
Debt / EBITDA Ratio
-0.81-0.81-0.02-0.96-1.62-1.02
Debt / FCF Ratio
-0.82-0.82-0.04-1.06-1.79-0.95
Net Debt / Equity Ratio
-2.15-2.15-1.08-1.56-1.15-1.03
Net Debt / EBITDA Ratio
0.130.130.440.310.520.72
Net Debt / FCF Ratio
0.130.130.730.340.580.67
Asset Turnover
0.010.010.000.010.010.05
Quick Ratio
3.683.683.764.959.945.89
Current Ratio
3.933.933.945.2510.176.20
Return on Equity (ROE)
-197.85%-197.85%1905.92%-475.31%-263.00%-127.91%
Return on Assets (ROA)
-82.52%-82.52%-135.66%-73.22%-58.51%-52.05%
Return on Invested Capital (ROIC)
1338.29%1338.29%1880.87%1335.92%-26137.60%6925.90%
Return on Capital Employed (ROCE)
-106.86%-106.86%-169.27%-85.15%-65.99%-63.71%
Earnings Yield
-7.43%-11.44%731.30%-53.89%-14.69%-4.92%
FCF Yield
-6.89%-11.27%-88.37%-10.99%-10.81%-4.77%
Buyback Yield / Dilution
-3.36%-3.36%-27.17%70.62%-5.52%-50.47%
Total Shareholder Return
-3.36%-3.36%-27.17%70.62%-5.52%-50.47%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q